Mental health
Depression, anxiety and psychosis in pregnancy and after birth.
Conditions 3
-
Depression that starts during pregnancy or after a baby is born. It can range from mild to severe, can make it hard to do daily tasks or care for a baby, and can be treated. NIMH says most episodes...
-
Depression after childbirth. Many new mothers have short spells of low mood, tearfulness or worry known as the baby blues, which usually pass within a few days to a week. Postpartum depression is...
-
A rare, serious illness after childbirth in which a woman may have delusions, hallucinations, mania, paranoia and confusion. NIMH calls it a psychiatric emergency that requires hospital care, and...
Drugs 2
-
The active substance in Zulresso, a medicine given by drip into a vein over about 2.5 days in hospital to treat postpartum depression. It is a neuroactive steroid that acts on GABA-A receptors in the...
-
The active substance in Zurzuvae, a capsule for postpartum depression. It is a neuroactive steroid that acts on GABA-A receptors in the brain, as brexanolone does.
Fronts 3
-
Pages about medicines and vaccines given in pregnancy, at birth, after birth or to the baby. Each page says who receives it, the mother or the baby.
-
Pages about mood in pregnancy and after birth: how it is checked, and the talking therapies, medicines and peer support that exist.
-
Pages about the blood, urine, questionnaire and newborn tests that look for a problem before or soon after it shows. Each page says who is tested and what the test looks for.
Interventions 3
-
Talk-based support, such as cognitive behavioral therapy or interpersonal therapy, offered to pregnant and postpartum people who are at higher risk of developing depression, with the aim of...
-
A short set of questions about mood, sleep and thoughts that a health care provider may ask during pregnancy and after birth, to find people who may need a closer look. The answers help a provider...
-
A programme in which community health workers are trained to deliver a form of cognitive behaviour therapy to mothers with depression around the time of birth. A published manual describes it. In a...
Products 2
-
A medicine given as a continuous drip into a vein over 60 hours, with a health care provider on site, to treat postpartum depression. FDA approved it in 2019 for adults, and a 2022 label update...
-
A capsule taken by mouth once a day in the evening for 14 days to treat postpartum depression in adults. FDA approved it in August 2023 and described it as the first oral medicine for postpartum...
Technologies 1
-
A 10-question form that a mother fills in about her mood, first described in 1987, to help find postnatal depression in the community. It takes about 5 minutes and is scored in a simple way. It is a...
Guidelines 1
-
The 2019 statement from the US Preventive Services Task Force on preventing depression in pregnancy and after birth. It recommends that clinicians provide or refer pregnant and postpartum people at...
Publications 1
-
The report of the two phase 3 trials of brexanolone injection for postpartum depression, published in The Lancet in 2018.
Studies 2
-
Two trials that tested a single 60-hour drip of brexanolone against a placebo in women with postpartum depression: one in women with severe depression and one in women with moderate depression. Women...
-
A trial that tested a 14-day course of zuranolone capsules in women with severe postpartum depression. Women were randomly given zuranolone 50 mg a day or a placebo, and neither the women nor the...
Organizations 2
-
A non-profit organisation, founded in 1987, that offers information, a telephone help line, online support groups and trained volunteers for people affected by mood and anxiety problems around...
-
The United Nations agency for international public health.
Ideas 1
-
An idea tested in Massachusetts: give obstetric clinicians access to advice from a perinatal psychiatrist, plus resource and referral help, so they can find and treat mood problems in pregnancy and...